2026 data FDA MAUDE openFDA

Susceptibility Test Powders, Antimycobacterial

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Susceptibility Test Powders LIGHT-BOOK · MAUDE

#743 of 1000 · 756 reports · 2021–2026

  • BOOK 756 reports
  • RANK #743 of 1000
  • DEATH 0 death-typed
  • INJ 4 injury-typed
  • MALF 752 malfunction
  • SPAN 2021–2026
  • PEAK 2025: 533
  • PHOTO Enzyme Linked Immunoa…

Nearest event-volume peer: Enzyme Linked Immunoabsorbent Assay, Rubella (0 report gap)

Susceptibility Test Powders, Antimycobacterial sits #743 of 1000 among tracked device types with 756 MAUDE reports spanning 2021–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Event-type mix vs corpus

Shares of FDA event_type codes on this device type, compared with the mean across 1,000 device types that have ≥100 MAUDE reports. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 0.5% corpus 30.4% · below corpus mean (-29.9 pp)
  • MALF 99.5% corpus 64.5% · above corpus mean (+35.0 pp)

Lead product-problem code Incorrect, Inadequate or Imprecise Result or Readings is 98% of coded problems · Lead manufacturer BECTON DICKINSON & CO. (SPARKS) accounts for 70% of manufacturer-tagged reports · Top event location is 100% of location-tagged rows .

Susceptibility Test Powders in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Susceptibility Test Powders, Antimycobacterial carries 756 MAUDE reports, ranked #743 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 752 (99.5%)
Injury 4 (0.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

729 (96.4%)
Other 26 (3.4%)
Required Intervention 1 (0.1%)

Top Product Problems

Incorrect, Inadequate or Imprecise Result or Readings 721
Contamination 5
False Positive Result 4
Contamination of Device Ingredient or Reagent 2
Device Markings/Labelling Problem 2
Non Reproducible Results 1

Yearly Trend

21
2021: 5
22
2022: 10
23
2023: 43
24
2024: 164
25
2025: 533
26
2026: 1

Related Entities for Susceptibility Test Powders, Antimycobacterial

Compare BECTON DICKINSON & CO. (SPARKS) vs BECTON, DICKINSON & CO. (SPARKS) →

Nationwide devices with similar MAUDE profiles

Two openFDA-derived peer sets for Susceptibility Test Powders, both floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (756 here).

Similar death-typed counts

Nearest other device types by death-typed report count (0 here), distinct from the volume row.

Disclaimer: MAUDE figures for Susceptibility Test Powders are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Susceptibility Test Powders; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.